Patient | Dose (mg) | Cmax (μg/mL) | Tmax (d) | AUC0-∞ (μgd/mL) | t1/2 (d) | CL/F(L/d) | Vz/F(L) | CL/F/wt(L/d)/kg |
---|
1 | 34.8 | NE | NE | NE | NE | NE | NE | NE |
2 | 36.0 | 13.6 | 6.96 | 580 | 25.7 | 0.0621 | 2.3 | 0.0034 |
3 | 46.6 | 7.67 | 2 | NE | NE | NE | NE | NE |
4 | 48.0 | NE | NE | NE | NE | NE | NE | NE |
5 | 71.0 | 12.4 | 2 | 543 | 23.7 | 0.131 | 4.48 | 0.0037 |
6 | 150.0 | 16.3 | 7.05 | 647 | 22.9 | 0.232 | 7.67 | 0.0048 |
7 | 150.0 | 10.4 | 2.16 | NE | NE | NE | NE | NE |
- NE: : non-estimable
- Cmax, Maximum (peak) serum drug concentration after drug administration; Tmax, Time to reach peak or maximum concentration following drug administration; AUC0∞, Area under the concentration-time curve from time zero to infinity; t1/2, The elimination half-life associated with the terminal slope (λz) of a semi logarithmic concentration-time curve; CL/F, The apparent total clearance from serum; Vz/F, The apparent volume of distribution during terminal phase